The association of HLA-DRB1 and HLA-DQB1 alleles with genetic susceptibility to multiple sclerosis in the Slovak population. 2015

Jozef Michalik, and Daniel Čierny, and Ema Kantorová, and Daniela Kantárová, and Javor Juraj, and Zuzana Párnická, and Egon Kurča, and Dušan Dobrota, and Ján Lehotský
1 Clinic of Neurology, Jessenius Faculty of Medicine and University Hospital in Martin, Comenius University in Bratislava , Martin, Slovakia.

OBJECTIVE The aim of the present study was to assess the association between HLA-DRB1 and -DQB1 allele groups with the genetic predisposition to multiple sclerosis (MS) in the Caucasian Central European Slovak population. METHODS A total of 282 unrelated patients with sporadic MS were enrolled in this case-control study. HLA-DRB1 and HLA-DQB1 allele groups were genotyped using a polymerase chain reaction with sequence-specific primers. The DRB1 and DQB1 allele carrier frequencies, genotypes and haplotype frequencies were compared between MS cases and healthy controls. RESULTS Positive association with MS was found for alleles HLA-DRB1*15 (OR = 3.64; Pcor = 6.9x10-11), DRB1*03 (after elimination of carriers of DRB1*15, OR = 2.8; Pcor = 0.0029), DQB1*06 (OR = 1.99; Pcor = 7.0x10-4), genotypes HLA-DRB1*15/*15 (OR = 7.6; Pcor = 0.001) and DQB1*06/*06 (OR = 3.81; Pcor = 4.0x10-4) and for haplotype DRB1*15-DQB1*06 (OR = 3.03; Pcor = 0.001). Carriage of alleles DRB1*07 (OR = 0.53; Pcor = 0.04), DRB1*13 (OR = 0.39; Pcor = 4.0x10-4), DQB1*03 (OR = 0.46; Pcor = 1.0x10-4), genotypes HLA-DRB1*13/*11 (OR = 0.12; Pcor = 0.004), DQB1*05/*03 (OR = 0.39; Pcor = 0.035), DQB1*03/*03 (OR = 0.38; Pcor = 0.029) and haplotypes DRB1*13-DQB1*06 (OR = 0.47; Pcor = 0.0128) and DRB1*11-DQB1*03 (OR = 0.58; Pcor = 0.0352) was found to be protective against MS development. CONCLUSIONS This is the first study performed to analyse the association of HLA-DRB1/DQB1 with susceptibility to MS in Slovakia. The results of our study confirm that HLA class II alleles, genotypes and haplotypes are associated with MS risk.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009103 Multiple Sclerosis An autoimmune disorder mainly affecting young adults and characterized by destruction of myelin in the central nervous system. Pathologic findings include multiple sharply demarcated areas of demyelination throughout the white matter of the central nervous system. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction. The usual pattern is one of recurrent attacks followed by partial recovery (see MULTIPLE SCLEROSIS, RELAPSING-REMITTING), but acute fulminating and chronic progressive forms (see MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE) also occur. (Adams et al., Principles of Neurology, 6th ed, p903) MS (Multiple Sclerosis),Multiple Sclerosis, Acute Fulminating,Sclerosis, Disseminated,Disseminated Sclerosis,Sclerosis, Multiple
D005260 Female Females
D005787 Gene Frequency The proportion of one particular in the total of all ALLELES for one genetic locus in a breeding POPULATION. Allele Frequency,Genetic Equilibrium,Equilibrium, Genetic,Allele Frequencies,Frequencies, Allele,Frequencies, Gene,Frequency, Allele,Frequency, Gene,Gene Frequencies
D005838 Genotype The genetic constitution of the individual, comprising the ALLELES present at each GENETIC LOCUS. Genogroup,Genogroups,Genotypes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D055815 Young Adult A person between 19 and 24 years of age. Adult, Young,Adults, Young,Young Adults
D056726 Genetic Association Studies The analysis of a sequence such as a region of a chromosome, a haplotype, a gene, or an allele for its involvement in controlling the phenotype of a specific trait, metabolic pathway, or disease. Candidate Gene Identification,Candidate Gene Analysis,Candidate Gene Association Studies,Candidate Gene Association Study,Gene Discovery,Genotype-Phenotype Association,Genotype-Phenotype Associations,Genotype-Phenotype Correlation,Genotype-Phenotype Correlations,Analyses, Candidate Gene,Analysis, Candidate Gene,Association Studies, Genetic,Association Study, Genetic,Association, Genotype-Phenotype,Associations, Genotype-Phenotype,Candidate Gene Analyses,Correlation, Genotype-Phenotype,Correlations, Genotype-Phenotype,Discovery, Gene,Gene Analyses, Candidate,Gene Analysis, Candidate,Gene Identification, Candidate,Genetic Association Study,Genotype Phenotype Association,Genotype Phenotype Associations,Genotype Phenotype Correlation,Genotype Phenotype Correlations,Identification, Candidate Gene,Studies, Genetic Association,Study, Genetic Association

Related Publications

Jozef Michalik, and Daniel Čierny, and Ema Kantorová, and Daniela Kantárová, and Javor Juraj, and Zuzana Párnická, and Egon Kurča, and Dušan Dobrota, and Ján Lehotský
January 1994, Human immunology,
Jozef Michalik, and Daniel Čierny, and Ema Kantorová, and Daniela Kantárová, and Javor Juraj, and Zuzana Párnická, and Egon Kurča, and Dušan Dobrota, and Ján Lehotský
January 2013, Bratislavske lekarske listy,
Jozef Michalik, and Daniel Čierny, and Ema Kantorová, and Daniela Kantárová, and Javor Juraj, and Zuzana Párnická, and Egon Kurča, and Dušan Dobrota, and Ján Lehotský
July 2013, Folia microbiologica,
Jozef Michalik, and Daniel Čierny, and Ema Kantorová, and Daniela Kantárová, and Javor Juraj, and Zuzana Párnická, and Egon Kurča, and Dušan Dobrota, and Ján Lehotský
November 1998, Bratislavske lekarske listy,
Jozef Michalik, and Daniel Čierny, and Ema Kantorová, and Daniela Kantárová, and Javor Juraj, and Zuzana Párnická, and Egon Kurča, and Dušan Dobrota, and Ján Lehotský
May 2007, Acta neurologica Scandinavica,
Jozef Michalik, and Daniel Čierny, and Ema Kantorová, and Daniela Kantárová, and Javor Juraj, and Zuzana Párnická, and Egon Kurča, and Dušan Dobrota, and Ján Lehotský
May 1998, Tissue antigens,
Jozef Michalik, and Daniel Čierny, and Ema Kantorová, and Daniela Kantárová, and Javor Juraj, and Zuzana Párnická, and Egon Kurča, and Dušan Dobrota, and Ján Lehotský
January 2022, Annals of laboratory medicine,
Jozef Michalik, and Daniel Čierny, and Ema Kantorová, and Daniela Kantárová, and Javor Juraj, and Zuzana Párnická, and Egon Kurča, and Dušan Dobrota, and Ján Lehotský
January 2016, Immunological investigations,
Jozef Michalik, and Daniel Čierny, and Ema Kantorová, and Daniela Kantárová, and Javor Juraj, and Zuzana Párnická, and Egon Kurča, and Dušan Dobrota, and Ján Lehotský
January 2005, Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban,
Jozef Michalik, and Daniel Čierny, and Ema Kantorová, and Daniela Kantárová, and Javor Juraj, and Zuzana Párnická, and Egon Kurča, and Dušan Dobrota, and Ján Lehotský
January 2012, PloS one,
Copied contents to your clipboard!